시장조사 보고서 : 세계의 항말라리아 의약품 시장예측 2021년-2026년

■ 영문 제목 : Global Anti-Malarial Drug Market Growth 2021-2026
	■ 상품코드 : LPI-2108K200017 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 133 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 항말라리아 의약품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (열대 말라리아 원충, 삼일열 말라리아 원충, 사일열 말라리아 원충, 난형 말라리아 원충)와 용도별 시장규모 (병원 약국, 소매 약국, 전자 상거래, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 항말라리아 의약품 시장 점유율
- 지역별 항말라리아 의약품 시장규모
- 주요지역의 종류별 시장규모 (열대 말라리아 원충, 삼일열 말라리아 원충, 사일열 말라리아 원충, 난형 말라리아 원충)
- 주요지역의 용도별 시장규모 (병원 약국, 소매 약국, 전자 상거래, 기타)
- 미주의 항말라리아 의약품 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 항말라리아 의약품 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 항말라리아 의약품 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 항말라리아 의약품 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 항말라리아 의약품 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Anti-Malarial Drug will have significant change from previous year. By the most conservative estimates of global Anti-Malarial Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 667.7 million in 2019. Over the next five years the Anti-Malarial Drug market will register a 2.7% CAGR in terms of revenue, the global market size will reach US$ 742.5 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Malarial Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Malarial Drug Consumption 2016-2026
2.1.2 Anti-Malarial Drug Consumption CAGR by Region
2.2 Anti-Malarial Drug Segment by Type
2.2.1 Plasmodium Falciparum
2.2.2 Plasmodium Vivax
2.2.3 Plasmodium Malariae
2.2.4 Plasmodium Ovale
2.3 Anti-Malarial Drug Sales by Type
2.3.1 Global Anti-Malarial Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti-Malarial Drug Sale Price by Type (2016-2021)
2.4 Anti-Malarial Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E-Commerce
2.4.4 Others
2.5 Anti-Malarial Drug Sales by Application
2.5.1 Global Anti-Malarial Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Anti-Malarial Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti-Malarial Drug Sale Price by Application (2016-2021)

3 Global Anti-Malarial Drug by Company
3.1 Global Anti-Malarial Drug Sales Market Share by Company
3.1.1 Global Anti-Malarial Drug Sales by Company (2019-2021)
3.1.2 Global Anti-Malarial Drug Sales Market Share by Company (2019-2021)
3.2 Global Anti-Malarial Drug Revenue Market Share by Company
3.2.1 Global Anti-Malarial Drug Revenue by Company (2019-2021)
3.2.2 Global Anti-Malarial Drug Revenue Market Share by Company (2019-2021)
3.3 Global Anti-Malarial Drug Sale Price by Company
3.4 Global Manufacturers Anti-Malarial Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Malarial Drug Product Location Distribution
3.4.2 Players Anti-Malarial Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti-Malarial Drug by Region
4.1 Global Anti-Malarial Drug by Region
4.1.1 Global Anti-Malarial Drug Sales by Region
4.1.2 Global Anti-Malarial Drug Revenue by Region
4.2 Americas Anti-Malarial Drug Sales Growth
4.3 APAC Anti-Malarial Drug Sales Growth
4.4 Europe Anti-Malarial Drug Sales Growth
4.5 Middle East & Africa Anti-Malarial Drug Sales Growth

5 Americas
5.1 Americas Anti-Malarial Drug Sales by Country
5.1.1 Americas Anti-Malarial Drug Sales by Country (2016-2021)
5.1.2 Americas Anti-Malarial Drug Revenue by Country (2016-2021)
5.2 Americas Anti-Malarial Drug Sales by Type
5.3 Americas Anti-Malarial Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti-Malarial Drug Sales by Region
6.1.1 APAC Anti-Malarial Drug Sales by Region (2016-2021)
6.1.2 APAC Anti-Malarial Drug Revenue by Region (2016-2021)
6.2 APAC Anti-Malarial Drug Sales by Type
6.3 APAC Anti-Malarial Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti-Malarial Drug by Country
7.1.1 Europe Anti-Malarial Drug Sales by Country (2016-2021)
7.1.2 Europe Anti-Malarial Drug Revenue by Country (2016-2021)
7.2 Europe Anti-Malarial Drug Sales by Type
7.3 Europe Anti-Malarial Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti-Malarial Drug by Country
8.1.1 Middle East & Africa Anti-Malarial Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti-Malarial Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti-Malarial Drug Sales by Type
8.3 Middle East & Africa Anti-Malarial Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti-Malarial Drug Distributors
10.3 Anti-Malarial Drug Customer

11 Global Anti-Malarial Drug Market Forecast
11.1 Global Anti-Malarial Drug Forecast by Region
11.1.1 Global Anti-Malarial Drug Forecast by Regions (2021-2026)
11.2.2 Global Anti-Malarial Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anti-Malarial Drug Forecast by Type
11.7 Global Anti-Malarial Drug Forecast by Application

12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Anti-Malarial Drug Product Offered
12.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Ranbaxy
12.2.1 Ranbaxy Company Information
12.2.2 Ranbaxy Anti-Malarial Drug Product Offered
12.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Ranbaxy Main Business Overview
12.2.5 Ranbaxy Latest Developments
12.3 Zydus Cadila
12.3.1 Zydus Cadila Company Information
12.3.2 Zydus Cadila Anti-Malarial Drug Product Offered
12.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Zydus Cadila Main Business Overview
12.3.5 Zydus Cadila Latest Developments
12.4 Alvizia
12.4.1 Alvizia Company Information
12.4.2 Alvizia Anti-Malarial Drug Product Offered
12.4.3 Alvizia Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Alvizia Main Business Overview
12.4.5 Alvizia Latest Developments
12.5 Bayer
12.5.1 Bayer Company Information
12.5.2 Bayer Anti-Malarial Drug Product Offered
12.5.3 Bayer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Bayer Main Business Overview
12.5.5 Bayer Latest Developments
12.6 Ipca
12.6.1 Ipca Company Information
12.6.2 Ipca Anti-Malarial Drug Product Offered
12.6.3 Ipca Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ipca Main Business Overview
12.6.5 Ipca Latest Developments
12.7 Merck
12.7.1 Merck Company Information
12.7.2 Merck Anti-Malarial Drug Product Offered
12.7.3 Merck Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Merck Main Business Overview
12.7.5 Merck Latest Developments
12.8 F. Hoffmann-La Roche
12.8.1 F. Hoffmann-La Roche Company Information
12.8.2 F. Hoffmann-La Roche Anti-Malarial Drug Product Offered
12.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 F. Hoffmann-La Roche Main Business Overview
12.8.5 F. Hoffmann-La Roche Latest Developments
12.9 Novartis
12.9.1 Novartis Company Information
12.9.2 Novartis Anti-Malarial Drug Product Offered
12.9.3 Novartis Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Novartis Main Business Overview
12.9.5 Novartis Latest Developments
12.10 Pfizer
12.10.1 Pfizer Company Information
12.10.2 Pfizer Anti-Malarial Drug Product Offered
12.10.3 Pfizer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Pfizer Main Business Overview
12.10.5 Pfizer Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti-Malarial Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Plasmodium Falciparum
Table 3. Major Players of Plasmodium Vivax
Table 4. Major Players of Plasmodium Malariae
Table 5. Major Players of Plasmodium Ovale
Table 6. Global Anti-Malarial Drug Sales by Type (2016-2021) & (MT)
Table 7. Global Anti-Malarial Drug Sales Market Share by Type (2016-2021)
Table 8. Global Anti-Malarial Drug Revenue by Type (2016-2021) & ($ million)
Table 9. Global Anti-Malarial Drug Revenue Market Share by Type (2016-2021)
Table 10. Global Anti-Malarial Drug Sale Price by Type (2016-2021)
Table 11. Global Anti-Malarial Drug Sales by Application (2016-2021) & (MT)
Table 12. Global Anti-Malarial Drug Sales Market Share by Application (2016-2021)
Table 13. Global Anti-Malarial Drug Value by Application (2016-2021)
Table 14. Global Anti-Malarial Drug Revenue Market Share by Application (2016-2021)
Table 15. Global Anti-Malarial Drug Sale Price by Application (2016-2021)
Table 16. Global Anti-Malarial Drug Sales by Company (2019-2021) & (MT)
Table 17. Global Anti-Malarial Drug Sales Market Share by Company (2019-2021)
Table 18. Global Anti-Malarial Drug Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Anti-Malarial Drug Revenue Market Share by Company (2019-2021)
Table 20. Global Anti-Malarial Drug Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Anti-Malarial Drug Producing Area Distribution and Sales Area
Table 22. Players Anti-Malarial Drug Products Offered
Table 23. Anti-Malarial Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Anti-Malarial Drug Sales by Region (2016-2021) (MT)
Table 27. Global Anti-Malarial Drug Sales Market Share by Region (2016-2021)
Table 28. Global Anti-Malarial Drug Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Anti-Malarial Drug Revenue Market Share by Region (2016-2021)
Table 30. Americas Anti-Malarial Drug Sales by Country (2016-2021) & (MT)
Table 31. Americas Anti-Malarial Drug Sales Market Share by Country (2016-2021)
Table 32. Americas Anti-Malarial Drug Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Anti-Malarial Drug Revenue Market Share by Country (2016-2021)
Table 34. Americas Anti-Malarial Drug Sales by Type (2016-2021) & (MT)
Table 35. Americas Anti-Malarial Drug Sales Market Share by Type (2016-2021)
Table 36. Americas Anti-Malarial Drug Sales by Application (2016-2021) & (MT)
Table 37. Americas Anti-Malarial Drug Sales Market Share by Application (2016-2021)
Table 38. APAC Anti-Malarial Drug Sales by Region (2016-2021) & (MT)
Table 39. APAC Anti-Malarial Drug Sales Market Share by Region (2016-2021)
Table 40. APAC Anti-Malarial Drug Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Anti-Malarial Drug Revenue Market Share by Region (2016-2021)
Table 42. APAC Anti-Malarial Drug Sales by Type (2016-2021) & (MT)
Table 43. APAC Anti-Malarial Drug Sales Market Share by Type (2016-2021)
Table 44. APAC Anti-Malarial Drug Sales by Application (2016-2021) & (MT)
Table 45. APAC Anti-Malarial Drug Sales Market Share by Application (2016-2021)
Table 46. Europe Anti-Malarial Drug Sales by Country (2016-2021) & (MT)
Table 47. Europe Anti-Malarial Drug Sales Market Share by Country (2016-2021)
Table 48. Europe Anti-Malarial Drug Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Anti-Malarial Drug Revenue Market Share by Country (2016-2021)
Table 50. Europe Anti-Malarial Drug Sales by Type (2016-2021) & (MT)
Table 51. Europe Anti-Malarial Drug Sales Market Share by Type (2016-2021)
Table 52. Europe Anti-Malarial Drug Sales by Application (2016-2021) & (MT)
Table 53. Europe Anti-Malarial Drug Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Anti-Malarial Drug Sales by Country (2016-2021) & (MT)
Table 55. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Anti-Malarial Drug Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Anti-Malarial Drug Sales by Type (2016-2021) & (MT)
Table 59. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Anti-Malarial Drug Sales by Application (2016-2021) & (MT)
Table 61. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application (2016-2021)
Table 62. Global Anti-Malarial Drug Sales Forecast by Type (2021-2026) & (MT)
Table 63. Global Anti-Malarial Drug Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Anti-Malarial Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Anti-Malarial Drug Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Anti-Malarial Drug Sales Forecast by Application (2021-2026) & (MT)
Table 67. Global Anti-Malarial Drug Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Anti-Malarial Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Anti-Malarial Drug Revenue Market Share Forecast by Application (2021-2026)
Table 70. GlaxoSmithKline Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 71. GlaxoSmithKline Anti-Malarial Drug Product Offered
Table 72. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 73. GlaxoSmithKline Main Business
Table 74. GlaxoSmithKline Latest Developments
Table 75. Ranbaxy Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Ranbaxy Anti-Malarial Drug Product Offered
Table 77. Ranbaxy Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 78. Ranbaxy Main Business
Table 79. Ranbaxy Latest Developments
Table 80. Zydus Cadila Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Zydus Cadila Anti-Malarial Drug Product Offered
Table 82. Zydus Cadila Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 83. Zydus Cadila Main Business
Table 84. Zydus Cadila Latest Developments
Table 85. Alvizia Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Alvizia Anti-Malarial Drug Product Offered
Table 87. Alvizia Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 88. Alvizia Main Business
Table 89. Alvizia Latest Developments
Table 90. Bayer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Bayer Anti-Malarial Drug Product Offered
Table 92. Bayer Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 93. Bayer Main Business
Table 94. Bayer Latest Developments
Table 95. Ipca Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Ipca Anti-Malarial Drug Product Offered
Table 97. Ipca Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 98. Ipca Main Business
Table 99. Ipca Latest Developments
Table 100. Merck Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck Anti-Malarial Drug Product Offered
Table 102. Merck Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 103. Merck Main Business
Table 104. Merck Latest Developments
Table 105. F. Hoffmann-La Roche Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. F. Hoffmann-La Roche Anti-Malarial Drug Product Offered
Table 107. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 108. F. Hoffmann-La Roche Main Business
Table 109. F. Hoffmann-La Roche Latest Developments
Table 110. Novartis Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Novartis Anti-Malarial Drug Product Offered
Table 112. Novartis Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 113. Novartis Main Business
Table 114. Novartis Latest Developments
Table 115. Pfizer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Anti-Malarial Drug Product Offered
Table 117. Pfizer Anti-Malarial Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Anti-Malarial Drug
Figure 2. Anti-Malarial Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Malarial Drug Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Anti-Malarial Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti-Malarial Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Plasmodium Falciparum
Figure 10. Product Picture of Plasmodium Vivax
Figure 11. Product Picture of Plasmodium Malariae
Figure 12. Product Picture of Plasmodium Ovale
Figure 13. Global Anti-Malarial Drug Sales Market Share by Type in 2020
Figure 14. Global Anti-Malarial Drug Revenue Market Share by Type (2016-2021)
Figure 15. Anti-Malarial Drug Consumed in Hospital Pharmacy
Figure 16. Global Anti-Malarial Drug Market: Hospital Pharmacy (2016-2021) & (MT)
Figure 17. Anti-Malarial Drug Consumed in Retail Pharmacy
Figure 18. Global Anti-Malarial Drug Market: Retail Pharmacy (2016-2021) & (MT)
Figure 19. Anti-Malarial Drug Consumed in E-Commerce
Figure 20. Global Anti-Malarial Drug Market: E-Commerce (2016-2021) & (MT)
Figure 21. Anti-Malarial Drug Consumed in Others
Figure 22. Global Anti-Malarial Drug Market: Others (2016-2021) & (MT)
Figure 23. Global Anti-Malarial Drug Sales Market Share by Application (2016-2021)
Figure 24. Global Anti-Malarial Drug Revenue Market Share by Application in 2020
Figure 25. Global Anti-Malarial Drug Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Anti-Malarial Drug Revenue Market Share by Company in 2020
Figure 27. Global Anti-Malarial Drug Sales Market Share by Regions (2016-2021)
Figure 28. Global Anti-Malarial Drug Revenue Market Share by Region in 2020
Figure 29. Americas Anti-Malarial Drug Sales 2016-2021 (MT)
Figure 30. Americas Anti-Malarial Drug Revenue 2016-2021 ($ Millions)
Figure 31. APAC Anti-Malarial Drug Sales 2016-2021 (MT)
Figure 32. APAC Anti-Malarial Drug Revenue 2016-2021 ($ Millions)
Figure 33. Europe Anti-Malarial Drug Sales 2016-2021 (MT)
Figure 34. Europe Anti-Malarial Drug Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Anti-Malarial Drug Sales 2016-2021 (MT)
Figure 36. Middle East & Africa Anti-Malarial Drug Revenue 2016-2021 ($ Millions)
Figure 37. Americas Anti-Malarial Drug Sales Market Share by Country in 2020
Figure 38. Americas Anti-Malarial Drug Revenue Market Share by Country in 2020
Figure 39. Americas Anti-Malarial Drug Sales Market Share by Type in 2020
Figure 40. Americas Anti-Malarial Drug Sales Market Share by Application in 2020
Figure 41. United States Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Anti-Malarial Drug Sales Market Share by Region in 2020
Figure 46. APAC Anti-Malarial Drug Revenue Market Share by Regions in 2020
Figure 47. APAC Anti-Malarial Drug Sales Market Share by Type in 2020
Figure 48. APAC Anti-Malarial Drug Sales Market Share by Application in 2020
Figure 49. China Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Anti-Malarial Drug Sales Market Share by Country in 2020
Figure 56. Europe Anti-Malarial Drug Revenue Market Share by Country in 2020
Figure 57. Europe Anti-Malarial Drug Sales Market Share by Type in 2020
Figure 58. Europe Anti-Malarial Drug Sales Market Share by Application in 2020
Figure 59. Germany Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application in 2020
Figure 68. Egypt Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Anti-Malarial Drug Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles

※본 조사보고서 [세계의 항말라리아 의약품 시장예측 2021년-2026년] (코드 : LPI-2108K200017) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 항말라리아 의약품 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 항감염성 기관내 튜브 시장예측 2021년-2026년
LPI-2108K201068 / LP Information / 2021년 8월 / 본 조사보고서는 항감염성 기관내 튜브의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti-Infective Endotracheal Tube will have significant change from previous year. By the most conservative estimates of global Anti-Infective Endotracheal Tube market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 비강 약물 전달 장치 시장예측 2021년-2026년
LPI-2108K201625 / LP Information / 2021년 8월 / 본 조사보고서는 비강 약물 전달 장치의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Nasal Drug Delivery Devices will have significant change from previous year. By the most conservative estimates of global Nasal Drug Delivery Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 항 여드름 화장품 시장예측 2021년-2026년
LPI-2108K200005 / LP Information / 2021년 8월 / 본 조사보고서는 항 여드름 화장품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Acne Makeup will have significant change from previous year. By the most conservative estimates of global Anti Acne Makeup market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항-HA 항체 시장예측 2021년-2026년
LPI-2108K200011 / LP Information / 2021년 8월 / 본 조사보고서는 항-HA 항체의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of anti-HA Antibody will have significant change from previous year. By the most conservative estimates of global anti-HA Antibody market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 무침 약물 전달 시스템 시장예측 2021년-2026년
LPI-2108K201631 / LP Information / 2021년 8월 / 본 조사보고서는 무침 약물 전달 시스템의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2020 growth of Needle-Free Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Needle-Free Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 항비만약 시장예측 2021년-2026년
LPI-2108K200019 / LP Information / 2021년 8월 / 본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항소화성 궤양 치료약 시장예측 2021년-2026년
LPI-2108K201064 / LP Information / 2021년 8월 / 본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 정전기 방지 장갑 시장예측 2021년-2026년
LPI-2108K202602 / LP Information / 2021년 8월 / 본 조사보고서는 정전기 방지 장갑의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti-static Gloves will have significant change from previous year. By the most conservative estimates of global Anti-static Gloves market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 눈부심 방지 코팅 시장예측 2021년-2026년
LPI-2108K202862 / LP Information / 2021년 8월 / 본 조사보고서는 눈부심 방지 코팅의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti-Glare Coating will have significant change from previous year. By the most conservative estimates of global Anti-Glare Coating market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 정전기 방지제 시장예측 2021년-2026년
LPI-2108K202869 / LP Information / 2021년 8월 / 본 조사보고서는 정전기 방지제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Anti-static Agents will have significant change from previous year. By the most conservative estimates of global Anti-static Agents market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 339.4 million in 2019. Over...